Publikace UTB
Repozitář publikační činnosti UTB

Discrimination of resected glioma tissues using surface enhanced Raman spectroscopy and Au@ZrO2 plasmonic nanosensor

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title Discrimination of resected glioma tissues using surface enhanced Raman spectroscopy and Au@ZrO2 plasmonic nanosensor en
dc.contributor.author Ranc, Václav
dc.contributor.author Pavlačka, Ondřej
dc.contributor.author Kalita, Ondřej
dc.contributor.author Vaverka, Miroslav
dc.relation.ispartof Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
dc.identifier.issn 1386-1425 Scopus Sources, Sherpa/RoMEO, JCR
dc.identifier.issn 1873-3557 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2024
utb.relation.volume 305
dc.type article
dc.language.iso en
dc.publisher Elsevier B.V.
dc.identifier.doi 10.1016/j.saa.2023.123521
dc.relation.uri https://www.sciencedirect.com/science/article/pii/S1386142523012064
dc.relation.uri https://www.sciencedirect.com/science/article/pii/S1386142523012064/pdfft?md5=e4d1f22e83881edacb6d25638c12681e&pid=1-s2.0-S1386142523012064-main.pdf
dc.subject Raman spectroscopy en
dc.subject gliomas en
dc.subject nanomaterials en
dc.subject SERS en
dc.subject ZrO2 en
dc.subject Au nanospheres en
dc.description.abstract Gliomas present one of the most prevalent malignant tumors related to the central nervous system. Surgical extraction is still a preferred route for glioma treatment. Nonetheless, neurosurgeons still have a considerable challenge to detect actual margins of the targeted glioma intraoperatively and correctly because of its great natural infiltration. Here we evaluated the possibility of using surface-enhanced Raman spectroscopy to analyze freshly resected brain tissues. The developed method is based on the application of Au@ZrO2 nanosensor. The plasmonic properties of the sensor were first tested on the analysis of Rhodamine 6G, where concentrations down to 10-7 mol/L can be successfully detected. We also compared the performance of the nanosensor with silver plasmonic nanoparticles, where similar results were obtained regarding the reduction of the fluorescence background and enhancement of the intensity of the measured analytical signal. However, application of silver nanospheres led to increased variations in spectral data due to its probable aggregation. Applied ZrO2@Au nanosensor thus dramatically lowers the fluorescence present in the Raman data, and considerably improves the quality of the measured signal. The developed method allows for rapid discrimination between the glioma's periphery and central parts, which could serve as a steppingstone toward highly precise neurosurgery. en
utb.faculty Faculty of Humanities
dc.identifier.uri http://hdl.handle.net/10563/1011790
utb.identifier.scopus 2-s2.0-85174683670
utb.identifier.wok 001102890200001
utb.identifier.pubmed 37862838
utb.identifier.coden SAMCA
utb.source j-scopus
dc.date.accessioned 2024-02-02T10:29:28Z
dc.date.available 2024-02-02T10:29:28Z
dc.description.sponsorship H2020 WIDESPREAD-2020-5, (952063); NANO4TARMED consortium; National Cancer Research Institute, NCRI, (LX22NPO5102); European Commission, EC; Ministerstvo Školství, Mládeže a Tělovýchovy, MŠMT; Ministerstvo Zdravotnictví Ceské Republiky, MZCR, (NV19-04-00281)
dc.description.sponsorship Ministry of Health of the Czech Republic [NV19-04-00281]; NANO4TARMED consortium (H2020 WIDESPREAD-2020-5) [952063]; MEYS CR [LM2018129]; National Institute for Cancer Research (Programme EXCELES) - European Union-Next Generation EU [LX22NPO5102]
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.rights.access openAccess
utb.ou Department of Health Care Science
utb.contributor.internalauthor Kalita, Ondřej
utb.fulltext.sponsorship The work was supported by the Ministry of Health of the Czech Republic, grant nr. NV19-04-00281. Authors also thank NANO4TARMED consortium (H2020 WIDESPREAD-2020-5, project number 952063). The work was further supported by the MEYS CR (Large RI Project LM2018129 Czech-BioImaging) and by the project National Institute for Cancer Research (Programme EXCELES, ID Project No. LX22NPO5102)—Funded by the European Union—Next Generation EU.
utb.wos.affiliation [Ranc, Vaclav] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Hnevotinska 5, Olomouc 77515, Czech Republic; [Ranc, Vaclav] Fac Hosp Olomouc, Hnevotinska 5, Olomouc 77515, Czech Republic; [Pavlacka, Ondrej] Palacky Univ Olomouc, Fac Sci, Dept Math Anal & Applicat Math, 17 Listopadu 12, Olomouc, Czech Republic; [Kalita, Ondrej; Vaverka, Miroslav] Fac Hosp Olomouc, Dept Neurosurg, IP Pavlova 6, Olomouc 77520, Czech Republic; [Kalita, Ondrej] T Bata Univ Zlin, Fac Humanities, Dept Hlth Care Sci, Stefanikova 5670, Zlin 76001, Czech Republic
utb.scopus.affiliation Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and Faculty Hospital Olomouc, Hněvotínská 5, 775 15, Olomouc, Czech Republic; Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacký, University Olomouc, 17. Listopadu 12, Olomouc, Czech Republic; Department of Neurosurgery, Faculty Hospital Olomouc, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic; Department of Health Care Science, Faculty of Humanities, T. Bata University in Zlín, Štefanikova 5670, 760 01 Zlín, Czech Republic
utb.fulltext.projects NV19-04-00281
utb.fulltext.projects 952063
utb.fulltext.projects LM2018129
utb.fulltext.projects LX22NPO5102
Find Full text

Soubory tohoto záznamu

Zobrazit minimální záznam

Attribution 4.0 International Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Attribution 4.0 International